MGRX

89.75% 0.2635

アフターアワーズ： .45 -0.1071 -19.22%

Mangoceuticals Inc (MGRX)

概要ニュース株価時系列ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Mangoceuticals Inc Stock (MGRX) Company Profile

Mangoceuticals Inc

Healthcare (1079)

(833) 626-4679

15110 DALLAS PKWY, SUITE 600, DALLAS

MGRX's Discussions on Twitter

Compare MGRX vs VEEV, BTSG, HQY, TEM, TXG

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
MGRX Mangoceuticals Inc	0.5571	9.32M	414.60K	-19.21M	-4.89M	-1.6207
VEEV Veeva Systems Inc	203.77	31.59B	3.32B	941.65M	1.64B	5.6161
BTSG Brightspring Health Services Inc	59.74	14.13B	13.65B	169.86M	412.12M	1.0758
HQY Healthequity Inc	100.61	8.28B	1.34B	230.70M	440.96M	2.6695
TEM Tempus Ai Inc	43.87	7.73B	1.36B	-302.91M	-219.93M	-1.7182
TXG 10 X Genomics Inc	47.27	5.83B	638.78M	-22.66M	122.18M	-0.1744

Mangoceuticals Inc (MGRX) 最新ニュース

Mangoceuticals Inc (MGRX) 財務データ

Mangoceuticals Inc (MGRX) インサイダートレーディング

インサイダートレーディング	関係	日付	取引	コスト	#株式	値 ($)	#株式総数
JOHNSTON EUGENE M	CFO	Dec 09 '25	Sale	1.20	5,000	5,975	123,333
JOHNSTON EUGENE M	CFO	Dec 05 '25	Sale	1.13	10,000	11,280	128,333

Mangoceuticals Inc (MGRX)

Mangoceuticals Inc Stock (MGRX) Company Profile

Compare MGRX vs VEEV, BTSG, HQY, TEM, TXG

Mangoceuticals Inc (MGRX) 最新ニュース

Mangoceuticals Inc (MGRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Mangoceuticals Inc (MGRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Mangoceuticals Inc (MGRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Mangoceuticals Inc (MGRX) Cash Flow - TradingKey

Mangoceuticals Inc (MGRX) Income Statement - TradingKey

MGRX|Mangoceuticals Inc|Price:0.542|Chg%:-0.001 - TradingKey

MGRX|Mangoceuticals Inc|Price:0.521|Chg%:-0.037 - TradingKey

Mangoceuticals Inc (MGRX) Institutional Confidence - TradingKey

Mangoceuticals, Inc. Revenue Breakdown – NASDAQ:MGRX - TradingView

Mangoceuticals Inc (MGRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Mangoceuticals stock doubles after Texas lawsuit - MSN

MGRX Q3 2025 Earnings: Net Loss Widens as Pre-Revenue Biotech Focuses on Clinical PipelineEarnings Outlook Update - DonanımHaber

Price to sales forward of Mangoceuticals, Inc. – BOATS:MGRX - TradingView

Mangoceuticals (MGRX) Slips 2.46% as Stock Approaches Key Support at $0.34Time Weighted Price - dars.gov.et

MGRX Q3 2025 Earnings: Wider Loss Reported as Stock Gains Despite Opaque Financial DisclosureBasic EPS Analysis - dars.gov.et

Price to earnings forward of Mangoceuticals, Inc. – NASDAQ:MGRX - TradingView

ETFs Investing in Mangoceuticals, Inc. Stocks - TradingView

Mangoceuticals (MGRX) Surges 10% as Stock Bounces from Key Support LevelGEX Level - dars.gov.et

Mangoceuticals, Inc. Subscription Agreement: Accredited Investor Requirements & SEC Compliance Explained - Minichart

Mangoceuticals Raises Capital via Private Equity Placement - TipRanks

Mangoceuticals (MGRX) completes $272,000 private placement of common shares - Stock Titan

Mangoceuticals Inc. (MGRX) Faces Continued Pressure, Testing Key Support Near $0.34Strangle Setup - dars.gov.et

Mangoceuticals, Inc. announced that it has received $0.272 million in funding - marketscreener.com

Mangoceuticals Inc (MGRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Mangoceuticals (MGRX) Rallies 3.46% as Buyers Defend $0.34 SupportChannel Projection - dars.gov.et

Mangoceuticals Inc (MGRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Trending Stocks Today | Mangoceuticals Soars 41.16% Post-Market - Moomoo

MGRX Q3 2025 Earnings: Widening Losses and No Revenue as Mangoceuticals Navigates Pre‑Commercial Phase - dars.gov.et

MGRX Q3 2025 Earnings: EPS Loss of $0.69; Stock Declines 4.61% Amid Limited DataFinancial Data - DonanımHaber

Mangoceuticals Inc (MGRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Mangoceuticals Inc (MGRX) Valuation: PE, PB & Fair Value Analysis - TradingKey

MGRX Q3 2025 Earnings: Loss Per Share Pressures Stock as Revenue Remains UndisclosedPeak Earnings Alert - dars.gov.et

MGRX Q3 2025 Earnings: EPS Loss of -$0.69 Highlights Ongoing Operational ChallengesPerformance Review - newsline.com

MGRX Price Today: Mangoceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC

Mangoceuticals (MGRX) Proxy Filing Summary - Quartr

MGRX Q3 2025 Earnings: Loss Reported, No Revenue Disclosed as Stock DeclinesLong-Term Guidance - dars.gov.et

MGRX Technical Analysis & Stock Price Forecast - Intellectia AI

Number of shareholders of Mangoceuticals, Inc. – NASDAQ:MGRX - TradingView

MGRX Q3 2025 Earnings: EPS of -$0.69 Reflects Ongoing Investment; Shares Dip 2.56%Subscription Growth Report - The Legal Advocate

MGRX Q3 2025 Earnings: Narrowing Losses as Strategic Pivot Gains MomentumSaaS Earnings Trends - DonanımHaber

MGRXMangoceuticals Inc Stock Price and Quote - Finviz

MGRX Q3 2025 Earnings: EPS Surprises with -$0.69 Loss as Revenue Remains UndisclosedROA Comparison - The Legal Advocate

Mangoceuticals Inc. (MGRX) Holds Near $0.44 After Marginal Uptick — Support and Resistance TightenVolume Profile - Newser

MANGOCEUTICALS, INC. 1Q 2026: Revenue $67.9K, EPS $(0.22) — 10-Q Summary - TradingView

Mangoceuticals (NASDAQ: MGRX) Q1 2026 shows small sales, heavy loss and thin cash - Stock Titan

MGRX: Net loss narrowed but liquidity and Nasdaq compliance risks persist, requiring urgent funding - TradingView

Mangoceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

Mangoceuticals Delays Quarterly Filing After Audit Review - TipRanks

[NT 10-Q] MANGOCEUTICALS, INC. SEC Filing - Stock Titan

MGRX Stock Price, Quote & Chart | MANGOCEUTICALS INC (NASDAQ:MGRX) - ChartMill

MGRX (Mangoceuticals) Q3 loss widens, but stock rallies 7% on positive outlook.Rating Upgrade - Newser

Mangoceuticals Inc (MGRX) 財務データ

収益

当期純利益

現金流量

EPS

Mangoceuticals Inc (MGRX) インサイダートレーディング

MGRXに似た銘柄